Cleared Traditional

K771244 - 2,2DIMETHOXY-2-PHENYLACETOPHENONE (FDA 510(k) Clearance)

K771244 · Solar Laboratories, Inc. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1977
Decision
63d
Days
-
Risk

K771244 is an FDA 510(k) clearance for the 2,2DIMETHOXY-2-PHENYLACETOPHENONE.

Submitted by Solar Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 12, 1977 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Physical Medicine FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Solar Laboratories, Inc. devices

Submission Details

510(k) Number K771244 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 1977
Decision Date September 12, 1977
Days to Decision 63 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 115d · This submission: 63d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code -
Device Class -